Open AccessLack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study
Author(s) -
Sridharan Gururangan,
Susan Chi,
Tina Young Poussaint,
Arzu OnarThomas,
Richard J. Gilbertson,
Sridhar Vajapeyam,
Henry S. Friedman,
Roger J. Packer,
Brian Rood,
James M. Boyett,
Larry E. Kun
Publication year - 2010
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2009.26.8789
Subject(s) - bevacizumab , medicine , glioma , irinotecan , gastroenterology , chemotherapy , cancer , colorectal cancer , cancer research
A phase II study of bevacizumab (BVZ) plus irinotecan (CPT-11) was conducted in children with recurrent malignant glioma (MG) and intrinsic brainstem glioma (BSG).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom